A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine

Launched by BOTANEE GROUP CO., LTD. · Mar 18, 2025

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • health females aged 35-60;
• • subjects with rough dark, loose fine lines;
• • no history of cosmetic allergies;
• • subjects are willing to use the test serum on split-face for 28 days;
• • subjects are willing to suffer the Fotona 4D treatment (Frac3 and Piano modes) on the face;
• • subjects are willing to use the basic skincare products for 28 days, and acceptable for split-face use of the test products or the control product for 14 days;
• • written informed consent and portrait right consent were obtained from all participants before study entry.
• Exclusion Criteria:
• • anyone who is pregnant, nursing an infant, or planning a pregnancy during the study;
• • subjects with known allergies or sensitivities to the ingredients in any of the study products;
• • any symptoms of facial flushing, erythema, papules, desquamation, or edema as evaluated by a physician prior to initial screening or Fotona4D Pro treatment;
• • unhealed skin lesions;
• • participated in any other clinical trial within one month;
• • received facial skin treatments including but not limited to lasers, chemical peels, and dermal fillers within one month;
• • taken/injected anti-allergy medication in the past one month;
• • participants in other clinical trials at the same time;
• • any subjects that the investigator considers ineligible.